by Laura Smith | Sep 2, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 26th – September 2nd, 2022 Effects of Δ9-Tetrahydrocannabinol (Δ9-THC) & Cannabidiol (CBD) on Salivation Results from animal studies showed that Δ9-THC, but not CBD treatment reduced basal salivation. However, CBD did reverse the...by Laura Smith | Aug 30, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 19th – August 26th, 2022 Low ∆9-Tetrahydrocannabinol (∆9-THC) Cannabis Oil for Fibromyalgia (FM) Treatment Study results showed that this cannabis extract was effective in reversing FM symptoms in a mouse model. Fibromyalgia (FM) is a...by Laura Smith | Aug 19, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 12th – August 19th, 2022 Post-Traumatic Stress Disorder (PTSD) & Cannabis Use During COVID-19 Individuals who reported an increase in cannabis consumption during the pandemic displayed worsening depressive symptoms, a new study...by Laura Smith | Aug 11, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 5th – August 12th, 2022 Cannabis Use & COVID-19 Symptoms Severity COVID-19 cannabis consumers reported better clinical outcomes compared to non-consumers, suggesting the need for additional investigations. The novel severe acute...by Laura Smith | Aug 5, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News July 29th – August 5th, 2022 Cannabis Use to Treat Perimenopause and Postmenopause Symptoms: Results from Survey 86.1% of participants reported using cannabis, with 78.7% to treat menopausal-related symptoms. There are 3 types of menopauses...by Laura Smith | Aug 3, 2022 | Communications, Weekly Cannabis News
July 22nd – July 29th, 2022 Effects of Cannabinol (CBN)-Based Solution in Mice Study results indicate that the water-soluble cannabinol compound, CBNight™ does not cause significant toxicity. Discovered nearly a century ago, cannabinol, otherwise known as CBN, is a...